Palvella Therapeutics, Inc - Asset Resilience Ratio

Latest as of December 2023: 23.19%

Palvella Therapeutics, Inc (PVLA) has an Asset Resilience Ratio of 23.19% as of December 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Palvella Therapeutics, Inc total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

$8.97 Million

Cash + Short-term Investments

Total Assets

$38.68 Million

All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio Trend (None–None)

This chart shows how Palvella Therapeutics, Inc's Asset Resilience Ratio has changed over time. See Palvella Therapeutics, Inc shareholders equity for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Palvella Therapeutics, Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see PVLA market cap overview.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$8.97 Million	23.19%
Total Liquid Assets	$8.97 Million	23.19%

Asset Resilience Insights

Good Liquidity Position: Palvella Therapeutics, Inc maintains a healthy 23.19% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.

Palvella Therapeutics, Inc Industry Peers by Asset Resilience Ratio

Compare Palvella Therapeutics, Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Fortress Biotech Inc NASDAQ:FBIO	Biotechnology	11.59%
Summit Therapeutics PLC NASDAQ:SMMT	Biotechnology	0.00%
Tubize-Fin BR:TUB	Biotechnology	0.05%
Apellis Pharmaceuticals Inc NASDAQ:APLS	Biotechnology	0.58%
Beijing Tiantan Biological Products Corp Ltd SHG:600161	Biotechnology	8.08%
BrightGene Bio Medical Technology C SHG:688166	Biotechnology	1.00%
BioArctic AB (publ) ST:BIOA-B	Biotechnology	72.35%
Chengzhi Shareholding Co Ltd SHE:000990	Biotechnology	6.73%

Annual Asset Resilience Ratio for Palvella Therapeutics, Inc (None–None)

The table below shows the annual Asset Resilience Ratio data for Palvella Therapeutics, Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
No yearly data available.

pp = percentage points

About Palvella Therapeutics, Inc

NASDAQ:PVLA USA Biotechnology

Market Cap

$1.50 Billion

Market Cap Rank

#9263 Global

#2456 in USA

Share Price

$126.84

Change (1 day)

-1.15%

52-Week Range

$20.51 - $148.34

All Time High

$148.34